Literature DB >> 29103486

Design of injectable agar-based composite hydrogel for multi-mode tumor therapy.

Chenyao Wu1, Jiulong Zhao2, Fei Hu1, Yuting Zheng1, Hailun Yang1, Shunjie Pan1, Shenghua Shi1, Xin Chen3, Shige Wang4.   

Abstract

We designed an injectable hydrogel by dissolving MoS2/Bi2S3-PEG (MBP), doxorubicin (DOX) and agar into water for the concurrent tumor photothermal and chemotherapy. The formed solution was able to be intra-tumorally (I.T.) administered into tumor at a relatively high temperature and automatically formed a hydrogel after cooling to body temperature. The resultant Agar/MBP/DOX (AMD) hydrogel can act as a macro-vessel to retain the MBP nanosheet and DOX and restrict their access to body fluid circulation. Moreover, AMD hydrogel did not compromise the photoacoustic and computed tomography imaging capacity, as well as the photothermal and chemotherapy efficiency of MBP nanosheets and DOX. The heat from the photothermal transformation of MBP nanosheet can promote the drug-release from the hydrogel and thus enable an on-demand drug release. Furthermore, antibiotics were also able to be encapsulated in the hydrogel to avoid the potential wound infection during tumor surgery.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agar; Hydrogel; Injectable; Phase-changeable; Synergistic tumor therapy

Mesh:

Substances:

Year:  2017        PMID: 29103486     DOI: 10.1016/j.carbpol.2017.10.024

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  8 in total

1.  RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.

Authors:  Sang Gon Lee; Chang Hyun Kim; Si Woo Sung; Eun Seok Lee; Min Su Goh; Ho Yub Yoon; Myung Joo Kang; Sangkil Lee; Young Wook Choi
Journal:  Int J Nanomedicine       Date:  2018-06-01

Review 2.  Injectable hydrogels delivering therapeutic agents for disease treatment and tissue engineering.

Authors:  Jin Hyun Lee
Journal:  Biomater Res       Date:  2018-09-26

3.  Nanohybrid hydrogels designed for transbuccal anesthesia.

Authors:  Lígia Nunes de Morais Ribeiro; Michelle Franz-Montan; Márcia Cristina Breitkreitz; Gustavo Henrique Rodrigues da Silva; Simone Ramos de Castro; Viviane Aparecida Guilherme; Daniele Ribeiro de Araújo; Eneida de Paula
Journal:  Int J Nanomedicine       Date:  2018-10-15

4.  Antibacterial properties of in situ and surface functionalized impregnation of silver sulfadiazine in polyacrylonitrile nanofiber mats.

Authors:  Sana Ullah; Motahira Hashmi; Davood Kharaghani; Muhammad Qamar Khan; Yusuke Saito; Takayuki Yamamoto; Jungsoon Lee; Ick Soo Kim
Journal:  Int J Nanomedicine       Date:  2019-04-16

5.  Amphiphilic nanogels: influence of surface hydrophobicity on protein corona, biocompatibility and cellular uptake.

Authors:  Tony Bewersdorff; Alexandra Gruber; Murat Eravci; Malti Dumbani; Daniel Klinger; Andrea Haase
Journal:  Int J Nanomedicine       Date:  2019-09-26

6.  Temperature and pH-responsive nano-hydrogel drug delivery system based on lysine-modified poly (vinylcaprolactam).

Authors:  Fatemeh Farjadian; Somayeh Rezaeifard; Mahsa Naeimi; Sahar Ghasemi; Soliman Mohammadi-Samani; Mark E Welland; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2019-08-30

7.  Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.

Authors:  Emanuela Esposito; Michela Campolo; Giovanna Casili; Marika Lanza; Domenico Franco; Alessia Filippone; Alessio F Peritore; Salvatore Cuzzocrea
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

8.  Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.

Authors:  Sinem Yaprak Karavana; Zeynep Ay Şenyiğit; Çağrı Çalışkan; Gülnur Sevin; Derya İlem Özdemir; Yalçın Erzurumlu; Sait Şen; Esra Baloğlu
Journal:  Drug Des Devel Ther       Date:  2018-07-02       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.